Buy Anti-HeV/NiV Glycoprotein G Antibody (HENV-26) (Mouse, IgG1, kappa) for ELISA, FCM, Neutralization

Anti-HeV/NiV Glycoprotein G Antibody (HENV-26)

Catalog #: RVV08003 Specific References (0) DATASHEET

SEC-HPLC for Anti-HeV/NiV Glycoprotein G Antibody (HENV-26) ?>

Western Blot for Anti-HeV/NiV Glycoprotein G Antibody (HENV-26) ?>

Immunofluorescence for Anti-HeV/NiV Glycoprotein G Antibody (HENV-26) ?>

Host species: Mouse

Isotype: IgG1, kappa

Applications: ELISA, FCM, Neutralization

Expression system: Mammalian Cells

Overview

Catalog No.

RVV08003

Expression system

Mammalian Cells

Species reactivity

Hendra virus (isolate Horse/Autralia/Hendra/1994) & Nipah virus

Host species

Mouse

Isotype

IgG1, kappa

Clonality

Monoclonal

Applications

ELISA, FCM, Neutralization

Target

G, Glycoprotein G, Attachment glycoprotein, Receptor binding protein, RBP

Concentration

3.09 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

O89343, Q9IH62

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

HENV-26

Note

For research use only.

Data Image

Bioactivity

Detects Nipah virus(NiV) Glycoprotein G in indirect ELISAs.
SEC-HPLC

The purity of this product is >95% as determined by SEC-HPLC.
Bioactivity

Detects Nipah virus G protein in indirect ELISA.
Bioactivity

Detects Hendra virus Glycoprotein G Protein in indirect ELISA.
Western Blot

Figure 2. Characterization of rVSV∆G-eGFP-NiVBD F/G: (A) Western blot analysis of purified rVSV-eGFP and rVSV∆G-eGFP-NiVBD F/G. The blot was probed with commercial monoclonal antibodies against NiV G (HENV-26) and NiV F (5B3) to confirm the presence of the respective proteins.
Data sourced from citation (PMID: 40872782)
Immunofluorescence

Figure 2. Characterization of rVSV∆G-eGFP-NiVBD F/G: (B) Immunofluorescence analysis of NiV F and G protein expression in BHK cells infected with rVSV∆G-eGFP-NiVBD F/G or rVSV-eGFP. The cells were stained with monoclonal antibodies against NiV G (HENV-26) and NiV F (5B3), followed by an Alexa Fluor 594-conjugated secondary antibody. Scale bar = 275 µm. Concentrated rVSV∆G-eGFP-NiVBD F/G and rVSV eGFP were negatively stained with phosphotungstic acid and probed with monoclonal antibodies against NiV G (HENV-26) and NiV F (5B3), followed by gold-conjugated secondary antibodies. Scale bar = 200 nm
Data sourced from citation (PMID: 40872782)
Bioactivity

Figure 4. Application of recombinant rVSV∆G-eGFP-NiVBD F/G in neutralization assays: (A) Neutralization potency of the monoclonal antibodies HENV-26 and HENV-32 against rVSV∆G-eGFP NiVBD F/G. The neutralizing antibody (VNA) titers of the HENV-26 and HENV-32 were determined against rVSV∆G-eGFP-NiVBD F/G and the control virus rVSV-eGFP. The data are presented as log2 VNA titers. ***, p < 0.001.
Data sourced from citation (PMID: 40872782)

References

Datasheet

Document Download

Anti-HeV/NiV Glycoprotein G Antibody (HENV-26).pdf

$ 372

Product specifications

100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here